This is particularly significant in light of the three muramidase resistance mechanisms
The term describes facial hollowing, looser skin, deeper folds, and a more aged appearance that can become noticeable after substantial weight loss on semaglutide, tirzepatide, or another GLP-1 medication
This decision is highly personal and should be made in partnership with a qualified bariatric care team that considers: Medical history Insurance eligibility Weight loss goals Long-term health outcomes What Patients in California Should Consider Next If you are currently usingor consideringGLP-1 medications and are concerned about insurance coverage, cost, or long-term sustainability, it may be time to explore all evidence-based weight loss options
Simonetti recommends checking the FDA's list of registered compounding pharmacies
"In recent weeks, Novo Nordisks commercial team increasingly pressured us to control clinical standards and steer patients to Wegovy regardless of whether it was clinically best for patients
Routes of Administration Subcutaneous injection (standard): Lower abdomen (most common), love handles, or outer thigh